新元科技(300472.SZ):一季度净利预降83.42%–93.92%
格隆汇4月9日丨新元科技(300472.SZ)披露2020年度第一季度业绩预告,预计归属于上市公司股东的净利润110万元–300万元,同比下降83.42%–93.92%。业绩变动原因如下:
1、受全球新冠肺炎疫情的影响,公司严格执行政府相继出台的关于延迟复工及人员流动等疫情防控政策,公司上下游客户复工推迟,公司项目的实施工作均受到不同程度的推迟,从而对公司2020年第一季度的生产经营产生了较大影响,归属于上市公司股东的净利润较上年同期同比下降。公司后续将密切关注疫情进展情况并积极应对,尽量降低疫情对公司生产、经营情况的影响。
2、本报告期非经常性损益对净利润的影响额约为38.69万元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.